Atlas Trials

Sangamo Therapeutics

28 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Sangamo Therapeutics

RecordFirmDate
Safety and Tolerability Study of ST-503 for Refractory Pain Due to Peripheral Neuropathy (Small Fiber Predominant, SFN) (NCT06980948)Sangamo Therapeutics2025-12-04
Long-Term Follow-Up of TX200-TR101 (STEADFAST Long Term) (NCT05987527)Sangamo Therapeutics2023-08-15
Long - Term Follow Up of Sickle Cell Disease and Beta-thalassemia Subjects Previously Exposed to BIVV003 or ST-400. (NCT05145062)Sangamo Therapeutics2021-12-21
Long-Term Follow-up of Subjects Who Were Treated With ST-920 (NCT05039866)Sangamo Therapeutics2021-08-16
Safety & Tolerability Study of Chimeric Antigen Receptor T-Reg Cell Therapy in Living Donor Renal Transplant Recipients (NCT04817774)Sangamo Therapeutics2021-03-17
Long Term Follow-up (LTFU) of Subjects Who Received SB-318, SB-913, or SB-FIX (NCT04628871)Sangamo Therapeutics2020-11-03
A Study to Assess the Safety, Tolerability, and Efficacy of BIVV003 for Autologous Hematopoietic Stem Cell Transplantation in Patients With Severe Sickle Cell Disease (NCT03653247)Sangamo Therapeutics2019-03-06
A Study to Assess the Safety, Tolerability, and Efficacy of ST-400 for Treatment of Transfusion-Dependent Beta-thalassemia (TDT) (NCT03432364)Sangamo Therapeutics2018-03-29

Track Sangamo Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.